FIELD: medicine.
SUBSTANCE: pharmacotherapeutic decision-making in metabolic syndrome of children and adolescents is ensured by evaluating body weight index and an integral oxidative status - oxidative chemoluminescence coefficient (OCC) if the OCC value is equal to or higher than 2093.8, metformin based pharmacotherapy is added with chofitol in therapeutic doses.
EFFECT: use of the method allows individualising indications to pharmacotherapy in inefficient metformin based monotherapy in children and adolescents with MS.
1 dwg, 1 tbl, 2 ex
Authors
Dates
2010-12-27—Published
2009-11-16—Filed